Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain

Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain
复制标题

DOI:
10.1177/0969141313492508
复制
发表时间:
2013-01-01
影响因子:
2.9
通讯作者:
von Wagner, Christian
von Wagner, Christian
中科院分区:
医学4区
文献类型:
--
作者:
Lo, Siu Hing;Waller, Jo;von Wagner, Christian

文献摘要

被引文献

相似文献

目的结直肠癌(CRC)的筛查率低于宫颈癌和乳腺癌。对测试本身的厌恶通常被认为是使用粪便隐血(FOB)测试筛查结直肠癌的障碍,但尚未对这三种测试进行正面比较。方法于2012年春季在英国招募50-80岁的女性(890名),作为TNS Research International基于人群的调查的一部分。在符合条件的年龄范围内的人被问及是否参加过乳房、宫颈或结直肠癌筛查。对于每次筛选测试,从未参加过的女性都被要求使用障碍清单说明她们的“主要原因”。结果:在符合条件的女性中,分别有67%、83%和90%的人报告曾接受过结直肠癌、宫颈癌和乳腺癌筛查。更多的社会经济贫困妇女不太可能报告任何筛查,单身妇女比已婚妇女更不可能报告结直肠癌或乳房筛查。年龄与参与无关。总的来说,在报告的障碍方面,两种测试之间几乎没有差异,但不喜欢该测试更常被用于CRC筛查。这是第一个比较参与有组织的结直肠癌、乳腺癌和宫颈癌筛查项目的障碍的研究。癌症筛查测试有许多障碍,但对该测试的厌恶似乎是CRC筛查的更大障碍。未参加一个以上项目的妇女在筛查方面可能面临更多的全球性障碍,例如癌症宿命论。研究结果表明,可以通过针对粪便取样的不愉快来提高CRC筛查的接受程度。
Objective Uptake of cancer screening tends to be lower for colorectal cancer (CRC) than cervical or breast cancer. Dislike of the test itself has often been identified as a barrier to CRC screening with the Faecal Occult Blood (FOB) test, but there have been no head-to-head comparisons of the three tests.Methods Women aged 50-80 (n 890) were recruited in spring 2012 as part of a populationbased TNS Research International survey in Great Britain. Those in the eligible age range were asked if they had ever participated in breast, cervical or CRC screening. For each screening test, women who had never participated were asked for their 'main reason' using a checklist of barriers.Results Among eligible women, 67%, 83% and 90% reported ever having been screened for CRC, cervical and breast cancer respectively. More socioeconomically deprived women were less likely to report any screening, and single women were less likely to report CRC or breast screening than married women. Age was not associated with participation. Overall there were few differences between tests in the reported barriers, but dislike of the test was endorsed more often for CRC screening.Conclusion This was the first study to compare barriers to participation in organised screening programmes for CRC, breast and cervical cancer. Cancer screening tests share many barriers, but dislike of the test appears to be a stronger barrier to CRC screening. Women who are nonparticipants in more than one programme may have more global barriers to screening, such as cancer fatalism. The findings suggest that uptake of CRC screening could be improved by targeting the unpleasantness of stool sampling.